https://pipelinereview.com/destiny-breast09-head-to-head-first-line-phase-3-trial-of-enhertu-initiated-in-patients-with-her2-positive-metastatic-breast-cancer/
DESTINY-Breast09 Head-to-Head First-Line Phase 3 Trial of ENHERTU® Initiated in Patients with HER2 Positive Metastatic Breast Cancer